Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
クイックコネクト

ジェネリック製剤

Finished Dosage Forms - Product List:

Download Brochure

Dr. Reddy’s Laboratories is a leading API supplier, with a presence in over 80 countries and a portfolio of 200+ ANDA filings and approved dossiers. Our offering goes beyond APIs and our global customers have access to high-quality dossiers and finished dosage forms.

Generics Product List
Therapy Area : 腫瘍学
Product Name Oral Inj Strength Dossier Status Connect
Bendamustine RTU 180 mg/ 4 ml, 100 mg/ 4 ml Filed
Bortezomib 3.5 mg Filed
Cabazitaxel 60 mg/ 1.5 ml Filed
Carfilzomib 30 mg/ml, 60 mg/ml Filed
Decitabine 50 mg Filed
Eribulin 1 mg/2 ml 開発中で
Fulvestrant 50 mg/ml Filed
Fosaprepitant 150 mg/ ml Filed
Liposomal Doxorubicin 20 mg/10 ml ,50 mg/25 ml Filed
Palonosetron 0.075 mg/5 ml, 0.25 mg/ 5 ml Filed
Pemetrexed 100 mg, 500 mg, 1000 mg Filed
Plerixafor 24 mg/1.2 ml Filed
Zoledronic Acid 4 mg/5 ml, 5 mg/100 ml, 4 mg/100 ml Filed
Abiraterone 250 mg Filed
Capecitabine 150 mg, 500 mg Filed
Dasatinib 20, 50, 70, 80,100 and 140 mg Filed
Enzalutamide 40 mg 開発中で
Everolimus 2.5, 5, 7.5, 10 mg 開発中で
Lenalidomide 2.5, 5, 10, 15, 20, 25 mg Filed
Lenvatinib 4, 10 mg 開発中で
Nilotinib 150, 200 mg 開発中で
Palbociclib 75, 100, 125 mg Filed
Pomalidomide 1,2,3,4 mg Filed
Fingolimod 0.5 mg Filed
Abiraterone 500 mg 開発中で
Imatinib Mesylate 100 MG AND 400 MG Filed
Carmustine 100 mg/vial Filed
Venetoclax 10 mg, 50 mg and 100 mg Filed
Sorafenib 200 mg Filed
Midostaurin 25 mg Filed
Sunitinib Malate 12.5 mg, 25 mg, 37.5 mg and 50 mg Filed
Nano Paclitaxel 100mg 開発中で
Axitinib 1mg, 3mg, 5mg, 7mg 開発中で
Cabozantinib 20 mg, 40 mg and 60 mg 開発中で
Sunitinib 12.5Mg;25Mg;37.5Mg;50Mg Filed
Tofacitinib XR Tofacitinib XR 開発中で
Pazopanib 200 and 400 mg 開発中で
Dimethyl Fumarate 120mg, 240mg 開発中で
Nintedanib 100 mg & 150 mg 開発中で
Azacitidine 100 mg Filed
Bendamustine 25, 100mg Filed
Therapy Area : 中枢神経系
Product Name Oral Inj Strength Dossier Status Connect
Glatiramer 20, 40 mg Filed
Sugammadex 100 mg/ml Filed
Pregabalin 25, 50, 75, 100, 150, 200, 225, 300 mg Filed
Therapy Area : 心臓血管
Product Name Oral Inj Strength Dossier Status Connect
Fondaparinux 2.5, 5, 7.5, 10mg Filed
Treprostinil 1, 2.5, 5, 10mg/ml Filed
Apixaban 2.5, 5mg Filed
Dabigatran 75 , 110, 150 mg Filed
Rivaroxaban 10, 15, 20 mg Filed
Sacubitril/ Valsartan 24/26, 49/51, 97/103 mg Filed
Ticagrelor 60, 90 mg Filed
Icosapent Ethy 1 g Filed
Therapy Area : 抗糖尿病
Product Name Oral Inj Strength Dossier Status Connect
Liraglutide 6mg/ml – 3 ml fill pen 開発中で
Canagliflozin + Metformin 150 mg/1000 mg, 150 mg/500 mg, 50mg/1000 mg, 50 mg/500 mg Filed
Linagliptin 5 mg Filed
Linagliptin + Metformin 2.5 mg/500 mg, 2.5 mg/850 mg, 2.5 mg/1000 mg Filed
Semaglutide 2mg/1.5mL; 4mg/3mL 開発中で
Therapy Area : 胃腸疾患
Product Name Oral Inj Strength Dossier Status Connect
Esomeprazole 20, 40mg Filed
Esomeprazole MG + Naproxen Na 20 mg/375 mg, 20 mg/500 mg Filed
Lansoprazole ODT 15 mg and 30 mg Filed
Therapy Area : その他
Product Name Oral Inj Strength Dossier Status Connect
Daptomycin 350, 500 mg Filed
Icatibant 30 mg base /3 ml PFS Filed
Iron Sucrose 100 mg/5 ml, 200 mg/10 ml, 50 mg/2.5 ml Filed
Sevelamer Carbonate 800 mg Filed
Valganciclovir 450 mg Filed
Isotretinoin 10mg, 20mg, 30mg and 40mg Filed
Varenicline 0.5 mg and 1 mg Filed
Ferric Carboxy Maltose 50mg/mL 開発中で
Teriparatide 0.6 mg/2.4 mL (0.25 mg/mL) 開発中で
Rifaximine 550mg 開発中で
Amphotericin B 50mg 開発中で
Mesalamine 250 and 500 mg 開発中で
阿普斯特 10, 20, 30 mg Filed
Therapy Area : Oncology / Acromegaly
Product Name Oral Inj Strength Dossier Status Connect
Octerotide 10mg, 20mg & 30mg 開発中で
Lanreotide 60mg/0.2mL, 90mg/0.3mL and 120mg/0.5mL 開発中で
Therapy Area : Anti-Obesity
Product Name Oral Inj Strength Dossier Status Connect
Liraglutide 6mg/ml – 3 ml fill pen 開発中で
Therapy Area : Immuno Suppressant
Product Name Oral Inj Strength Dossier Status Connect
Sirolimus 1 mg and 2 mg Filed
Tacrolimus 0.5 mg, 1 mg and 5 mg Filed
Therapy Area Product Name Dosage Form EU Approval Status US Approval Status
Oncology Doxorubicin Hydrochloride Liposome Injection, 20 mg/10 ml (2 mg/ml) and 50 mg/25 ml (2 mg/ml) Single-dose Vials Injection Under review Approved
Oncology Imatinib Mesylate Tablets 100/400 mg Tablets NA Approved
Oncology Imatinib Mesylate Capsules 50/100/400 mg Capsules Approved NA
Oncology Docetaxel Injection Concentrate and 80 mg/4 ml Injection Approved Approved
Oncology Bendamustine HCl Concentrate for Solution for Infusion 180 mg_4 ml Infusion Approved NA
Oncology Bendamustine Hydrochloride Injection 25 mg/Vial and 100 mg/Vial Injection NA Tentative Approved
Oncology Capecitabine Tablets 500 mg Tablets Approved Approved
Oncology Capecitabine Tablets 150 mg Tablets NA Approved
Oncology Fulvestrant Injection 250 mg/5 ml (50 mg/ml) Injection Approved Approved
Oncology Dasatinib 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, 140 mg Film tablet Tablets Under review Tentative Approved

Meet with our product experts in one-on-one virtual sessions

Our experts will answer your questions, provide advice, and help you understand our product better

Set Up a Meeting

X

Let’s discuss API sourcing

Join us at Hall - 9.1 | Booth - B48

28th-30th October 2025 Messe Frankfurt, Germany

Book a slot now